相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Peter A. Merkel et al.
ACR OPEN RHEUMATOLOGY (2020)
Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized, Double-Blind, Active-Controlled, Phase 3 Trial
Peter A. Merkel et al.
JMIR RESEARCH PROTOCOLS (2020)
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
Eli M. Miloslavsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David R. W. Jayne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow Bekker et al.
PLOS ONE (2016)
Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials
Joanna Robson et al.
RHEUMATOLOGY (2015)
The characterisation and determinants of quality of life in ANCA associated vasculitis
Neil Basu et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
With Complements from ANCA Mice
Ralph Kettritz
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Hong Xiao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases
N. Duru et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
Remi Goupil et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Antineutrophil cytoplasm antibody-associated vasculitis: recent developments
Shunsuke Furuta et al.
KIDNEY INTERNATIONAL (2013)
Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease
JulieAnne G. McGregor et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Endothelium-Neutrophil Interactions in ANCA-Associated Diseases
Lise Halbwachs et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)
Gunnar Tomasson et al.
ARTHRITIS CARE & RESEARCH (2012)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence
Luis Corral-Gudino et al.
RHEUMATOLOGY (2011)
Wegener's granulomatosis in Finland in 1981-2000: risk of dialysis-dependent renal disease
J. H. Takala et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2011)
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
Rachel B. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients
C. Charlier et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
Russell P. Rother et al.
NATURE BIOTECHNOLOGY (2007)
Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis
M Koutantji et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Predictors of survival and organ damage in Wegener's granulomatosis
W Koldingsnes et al.
RHEUMATOLOGY (2002)
分享论文
